학술논문
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial
Document Type
Article
Author
Hu, Huabin; Kang, Liang; Zhang, Jianwei; Wu, Zehua; Wang, Hui; Huang, Meijin; Lan, Ping; Wu, Xiaojian; Wang, Chao; Cao, Wuteng; Hu, Jiancong; Huang, Yan; Huang, Liang; Wang, Huaiming; Shi, Lishuo; Cai, Yue; Shen, Cailu; Ling, Jiayu; Xie, Xiaoyu; Cai, Yonghua; He, Xiaowen; Dou, Ruoxu; Zhou, Jiaming; Ma, Tenghui; Zhang, Xingwei; Luo, Shuangling; Deng, Weihao; Ling, Li; Liu, Hao; Deng, Yanhong
Source
In The Lancet Gastroenterology & Hepatology January 2022 7(1):38-48
Subject
Language
ISSN
2468-1253